Tirzepatide holds FDA approvals as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic weight management (2023) and for moderate-to-severe obstructive sleep apnea (2024), and it is EMA-approved as well
View Certificate of Analysis (1)
(PubMed) Disclaimer The Linus Pauling Institute's Micronutrient Information Center provides scientific information on the health aspects of dietary factors and supplements, food, and beverages for the general public
Grapefruit: Another citrus fruit that contains glutathione, grapefruit offers a tangy taste and numerous health benefits
Neutralizing IL-1 or IL-18 (the inflammasome products) is another approach: Anakinra (IL-1 receptor antagonist) has been used off-label in systemic inflammation settings and is attractive for short-term use around surgery to DAMPsen the IL-1 surge (115)
After three months, all the patients saw their skin improving, regardless of other treatments they were using